Global and United States Gram-positive Bacterial Infection Drugs Market Report & Forecast 2022-2028
SKU ID : QYR-20738049 | Publishing Date : 18-Apr-2022 | No. of pages : 97
Detailed TOC of Global and United States Gram-positive Bacterial Infection Drugs Market Report & Forecast 2022-2028
1 Study Coverage1.1 Gram-positive Bacterial Infection Drugs Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Gram-positive Bacterial Infection Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gram-positive Bacterial Infection Drugs Market Size for the Year 2017-2028
1.2.2 Global Gram-positive Bacterial Infection Drugs Market Size for the Year 2017-2028
1.3 Gram-positive Bacterial Infection Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Gram-positive Bacterial Infection Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Gram-positive Bacterial Infection Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Gram-positive Bacterial Infection Drugs Market Dynamics
1.4.1 Gram-positive Bacterial Infection Drugs Industry Trends
1.4.2 Gram-positive Bacterial Infection Drugs Market Drivers
1.4.3 Gram-positive Bacterial Infection Drugs Market Challenges
1.4.4 Gram-positive Bacterial Infection Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Gram-positive Bacterial Infection Drugs by Type
2.1 Gram-positive Bacterial Infection Drugs Market Segment by Type
2.1.1 Antibiotic
2.1.2 Antifungal
2.1.3 Others
2.2 Global Gram-positive Bacterial Infection Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028)
2.4 United States Gram-positive Bacterial Infection Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028)
3 Gram-positive Bacterial Infection Drugs by Application
3.1 Gram-positive Bacterial Infection Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Gram-positive Bacterial Infection Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028)
3.4 United States Gram-positive Bacterial Infection Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028)
4 Global Gram-positive Bacterial Infection Drugs Competitor Landscape by Company
4.1 Global Gram-positive Bacterial Infection Drugs Market Size by Company
4.1.1 Top Global Gram-positive Bacterial Infection Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Gram-positive Bacterial Infection Drugs Revenue by Player (2017-2022)
4.2 Global Gram-positive Bacterial Infection Drugs Concentration Ratio (CR)
4.2.1 Gram-positive Bacterial Infection Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Gram-positive Bacterial Infection Drugs in 2021
4.2.3 Global Gram-positive Bacterial Infection Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gram-positive Bacterial Infection Drugs Headquarters, Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Gram-positive Bacterial Infection Drugs Headquarters and Area Served
4.3.2 Global Gram-positive Bacterial Infection Drugs Companies Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Gram-positive Bacterial Infection Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Gram-positive Bacterial Infection Drugs Market Size by Company
4.5.1 Top Gram-positive Bacterial Infection Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gram-positive Bacterial Infection Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Gram-positive Bacterial Infection Drugs Market Size by Region
5.1 Global Gram-positive Bacterial Infection Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gram-positive Bacterial Infection Drugs Market Size by Region (2017-2028)
5.2.1 Global Gram-positive Bacterial Infection Drugs Market Size by Region: 2017-2022
5.2.2 Global Gram-positive Bacterial Infection Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gram-positive Bacterial Infection Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gram-positive Bacterial Infection Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Gram-positive Bacterial Infection Drugs Introduction
7.1.4 Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.1.5 Pfizer Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Gram-positive Bacterial Infection Drugs Introduction
7.2.4 Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.2.5 Sanofi Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Details
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Gram-positive Bacterial Infection Drugs Introduction
7.3.4 GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.3.5 GlaxoSmithKline Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Gram-positive Bacterial Infection Drugs Introduction
7.4.4 Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.4.5 Bayer Recent Development
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Details
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Introduction
7.5.4 Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.5.5 Bristol-Myers Squibb Recent Development
7.6 Novartis
7.6.1 Novartis Company Details
7.6.2 Novartis Business Overview
7.6.3 Novartis Gram-positive Bacterial Infection Drugs Introduction
7.6.4 Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.6.5 Novartis Recent Development
7.7 Merck
7.7.1 Merck Company Details
7.7.2 Merck Business Overview
7.7.3 Merck Gram-positive Bacterial Infection Drugs Introduction
7.7.4 Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.7.5 Merck Recent Development
7.8 AstraZeneca
7.8.1 AstraZeneca Company Details
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Gram-positive Bacterial Infection Drugs Introduction
7.8.4 AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.8.5 AstraZeneca Recent Development
7.9 Allergan
7.9.1 Allergan Company Details
7.9.2 Allergan Business Overview
7.9.3 Allergan Gram-positive Bacterial Infection Drugs Introduction
7.9.4 Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.9.5 Allergan Recent Development
7.10 Theravance Biopharma
7.10.1 Theravance Biopharma Company Details
7.10.2 Theravance Biopharma Business Overview
7.10.3 Theravance Biopharma Gram-positive Bacterial Infection Drugs Introduction
7.10.4 Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022)
7.10.5 Theravance Biopharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Gram-positive Bacterial Infection Drugs Market Report & Forecast 2022-2028
List of TablesTable 1. Gram-positive Bacterial Infection Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Gram-positive Bacterial Infection Drugs Market Trends
Table 3. Gram-positive Bacterial Infection Drugs Market Drivers
Table 4. Gram-positive Bacterial Infection Drugs Market Challenges
Table 5. Gram-positive Bacterial Infection Drugs Market Restraints
Table 6. Global Gram-positive Bacterial Infection Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Gram-positive Bacterial Infection Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Gram-positive Bacterial Infection Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Gram-positive Bacterial Infection Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Gram-positive Bacterial Infection Drugs Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Gram-positive Bacterial Infection Drugs Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Gram-positive Bacterial Infection Drugs Revenue Share by Player, 2017-2022
Table 13. Global Gram-positive Bacterial Infection Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gram-positive Bacterial Infection Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gram-positive Bacterial Infection Drugs as of 2021)
Table 15. Top Players of Gram-positive Bacterial Infection Drugs in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Gram-positive Bacterial Infection Drugs Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Gram-positive Bacterial Infection Drugs Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Gram-positive Bacterial Infection Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Gram-positive Bacterial Infection Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Gram-positive Bacterial Infection Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Gram-positive Bacterial Infection Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Gram-positive Bacterial Infection Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Gram-positive Bacterial Infection Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Gram-positive Bacterial Infection Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer Gram-positive Bacterial Infection Drugs Product
Table 33. Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. Sanofi Company Details
Table 36. Sanofi Business Overview
Table 37. Sanofi Gram-positive Bacterial Infection Drugs Product
Table 38. Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 39. Sanofi Recent Development
Table 40. GlaxoSmithKline Company Details
Table 41. GlaxoSmithKline Business Overview
Table 42. GlaxoSmithKline Gram-positive Bacterial Infection Drugs Product
Table 43. GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 44. GlaxoSmithKline Recent Development
Table 45. Bayer Company Details
Table 46. Bayer Business Overview
Table 47. Bayer Gram-positive Bacterial Infection Drugs Product
Table 48. Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 49. Bayer Recent Development
Table 50. Bristol-Myers Squibb Company Details
Table 51. Bristol-Myers Squibb Business Overview
Table 52. Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Product
Table 53. Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 54. Bristol-Myers Squibb Recent Development
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Gram-positive Bacterial Infection Drugs Product
Table 58. Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. Merck Company Details
Table 61. Merck Business Overview
Table 62. Merck Gram-positive Bacterial Infection Drugs Product
Table 63. Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 64. Merck Recent Development
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Gram-positive Bacterial Infection Drugs Product
Table 68. AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 69. AstraZeneca Recent Development
Table 70. Allergan Company Details
Table 71. Allergan Business Overview
Table 72. Allergan Gram-positive Bacterial Infection Drugs Product
Table 73. Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 74. Allergan Recent Development
Table 75. Theravance Biopharma Company Details
Table 76. Theravance Biopharma Business Overview
Table 77. Theravance Biopharma Gram-positive Bacterial Infection Drugs Product
Table 78. Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2017-2022) & (US$ Million)
Table 79. Theravance Biopharma Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Gram-positive Bacterial Infection Drugs Product Picture
Figure 2. Global Gram-positive Bacterial Infection Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Gram-positive Bacterial Infection Drugs Market Size 2017-2028 (US$ Million)
Figure 4. United States Gram-positive Bacterial Infection Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Gram-positive Bacterial Infection Drugs Market Size 2017-2028 (US$ Million)
Figure 6. United States Gram-positive Bacterial Infection Drugs Market Share in Global 2017-2028
Figure 7. Gram-positive Bacterial Infection Drugs Report Years Considered
Figure 8. Product Picture of Antibiotic
Figure 9. Product Picture of Antifungal
Figure 10. Product Picture of Others
Figure 11. Global Gram-positive Bacterial Infection Drugs Market Share by Type in 2022 & 2028
Figure 12. Global Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Gram-positive Bacterial Infection Drugs Market Share by Type (2017-2028)
Figure 14. United States Gram-positive Bacterial Infection Drugs Market Share by Type in 2022 & 2028
Figure 15. United States Gram-positive Bacterial Infection Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Gram-positive Bacterial Infection Drugs Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospital Pharmacies
Figure 18. Product Picture of Retail Pharmacies
Figure 19. Product Picture of Online Pharmacies
Figure 20. Global Gram-positive Bacterial Infection Drugs Market Share by Application in 2022 & 2028
Figure 21. Global Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Gram-positive Bacterial Infection Drugs Market Share by Application (2017-2028)
Figure 23. United States Gram-positive Bacterial Infection Drugs Market Share by Application in 2022 & 2028
Figure 24. United States Gram-positive Bacterial Infection Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Gram-positive Bacterial Infection Drugs Market Share by Application (2017-2028)
Figure 26. North America Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.A.E Gram-positive Bacterial Infection Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Pfizer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 55. Sanofi Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 57. Bayer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 62. Allergan Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 63. Theravance Biopharma Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Keyplayers in Global and United States Gram-positive Bacterial Infection Drugs Market Report & Forecast 2022-2028
PfizerSanofi
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novartis
Merck
AstraZeneca
Allergan
Theravance Biopharma